Matt Calistri | Vice President, Investor Relations |
Tony Coles | Chief Executive Officer |
Ray Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Kathy Yi | Chief Financial Officer |
Paul Matteis | Stifel |
Michael Yee | Jefferies |
Greg Suvannavejh | Goldman Sachs |
Good morning. Welcome to the Cerevel Therapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] Please note that this call maybe recorded. I will now hand the call over to Matt Calistri, Vice President of Investor Relations.